in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Venture Capital Investment in U.S. Biotech Hits 12-year Low
11:27 AM MDT | April 22, 2009 | Alex Scott
Venture capital investment in U.S. Biotech firms during the first quarter of the year fell 47%, compared with the year-ago period, to $3 billion, according to a report by PricewaterhouseCoopers (PWC) and the National Venture Capital Association (Boston, MA) based on data from Thomson Reuters. The investment in the sector in the U.S. is the lowest in 12 years, the authors say. The number of investment deals in the sector fell 37%, compared with the year-ago period, to 546. The report’s authors cited uncertainty among entrepreneurs and venture...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee